Cellebrite DI Ltd. - Ordinary Shares (CLBT)
19.23
+0.19 (1.00%)
Cellebrite Di Ltd is a technology company that specializes in digital intelligence solutions, primarily focused on the field of law enforcement and national security
They provide advanced tools and software designed for digital forensics, enabling organizations to extract and analyze data from mobile devices and other digital sources. Cellebrite's offerings help agencies investigate cybercrime, gather evidence, and enhance their overall operational efficiency in addressing criminal activities. Their innovative solutions are widely used to support investigations in various sectors, ensuring secure and reliable data retrieval.

Earnings news has catalyzed frenzied activity in these stocks, and irrespective of the directional moves, sentiment toward them has remained uniformly upbeat.
Via Stocktwits · February 18, 2025

In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha.
Via Talk Markets · February 14, 2025

Today's show is a cut of our members-only podcast, "Stock Advisor Roundtable."
Via The Motley Fool · September 11, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via Benzinga · February 15, 2024

Via Benzinga · August 16, 2024

CLBT stock results show that Cellebrite DI beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 15, 2024

Find out how might the rotation of funds into small-cap stocks and the Dow Jones affect the Nasdaq 100.
Via Talk Markets · July 24, 2024

Despite having a license for Cellebrite's software, the FBI's Pittsburgh bureau was unable to bypass the passcode on Crooks' newer Samsung model phone, which runs on Android's operating system.
Via Benzinga · July 19, 2024

Cellebrite DI reported strong Q1 FY24 results with revenue up 26% YoY, ARR at $331.8 million, and EPS beating consensus. Outlook remains positive with expected revenue of $90M-$94M in Q2 and $370M-$380M for FY24.
Via Benzinga · May 23, 2024

CLBT stock results show that Cellebrite DI beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 23, 2024

Via Benzinga · July 19, 2023

While quality matters in the market, these best stocks under $10 to buy gives you some potential diamonds in the rough.
Via InvestorPlace · May 3, 2023

In this week’s Dirty Dozen we cover more recession signals, bullish price action in the main markets, a big set up in the US dollar, a major compression regime in bonds, and more…
Via Talk Markets · May 1, 2023

While jitters abound, intrepid investors may target these compelling innovators.
Via InvestorPlace · March 20, 2023

Raymond James raised the price target for Jabil Inc. (NYSE: JBL) from $84 to $100. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares fell 0.7% to close at $81.35 on Monday.
Via Benzinga · March 14, 2023

Although the innovation space provides several compelling opportunities, you don’t have to pay full price with these tech stock bargains.
Via InvestorPlace · February 6, 2023

Companies Reporting Before The Bell • Jumia Technologies (NYSE:JMIA) is expected to report quarterly loss at $0.76 per share on revenue of $57.32 million.
Via Benzinga · November 17, 2022